361 related articles for article (PubMed ID: 11480882)
1. Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression.
Nierenberg AA; DeCecco LM
J Clin Psychiatry; 2001; 62 Suppl 16():5-9. PubMed ID: 11480882
[TBL] [Abstract][Full Text] [Related]
2. Treatment of major depression: is improvement enough?
Ferrier IN
J Clin Psychiatry; 1999; 60 Suppl 6():10-4. PubMed ID: 10235119
[TBL] [Abstract][Full Text] [Related]
3. A comparative meta-analysis of Clinical Global Impressions change in antidepressant trials.
Spielmans GI; McFall JP
J Nerv Ment Dis; 2006 Nov; 194(11):845-52. PubMed ID: 17102709
[TBL] [Abstract][Full Text] [Related]
4. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
5. Remission in depression: definition and initial treatment approaches.
Israel JA
J Psychopharmacol; 2006 May; 20(3 Suppl):5-10. PubMed ID: 16644766
[TBL] [Abstract][Full Text] [Related]
6. Clinical features of treatment-resistant depression.
Kornstein SG; Schneider RK
J Clin Psychiatry; 2001; 62 Suppl 16():18-25. PubMed ID: 11480880
[TBL] [Abstract][Full Text] [Related]
7. Eighteen months of drug treatment for depression: predicting relapse and recovery.
Mulder RT; Frampton CM; Luty SE; Joyce PR
J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, recognition, and treatment of comorbid depression and anxiety.
Rapaport MH
J Clin Psychiatry; 2001; 62 Suppl 24():6-10. PubMed ID: 11676431
[TBL] [Abstract][Full Text] [Related]
9. Treatment recommendations versus treatment realities: recognizing the rift and understanding the consequences.
Frank E; Judge R
J Clin Psychiatry; 2001; 62 Suppl 22():10-5. PubMed ID: 11599642
[TBL] [Abstract][Full Text] [Related]
10. Evaluating antidepressant therapies: remission as the optimal outcome.
Thase ME
J Clin Psychiatry; 2003; 64 Suppl 13():18-25. PubMed ID: 14552652
[TBL] [Abstract][Full Text] [Related]
11. Treatment of depressive disorders with and without medication - a naturalistic study.
Hasler G; Schnyder U; Klaghofer R; Angst J
Pharmacopsychiatry; 2002 Nov; 35(6):235-8. PubMed ID: 12518272
[TBL] [Abstract][Full Text] [Related]
12. The definition and meaning of treatment-resistant depression.
Sackeim HA
J Clin Psychiatry; 2001; 62 Suppl 16():10-7. PubMed ID: 11480879
[TBL] [Abstract][Full Text] [Related]
13. [Clinical criteria in evaluating recovery from depression. Methodologic aspects].
Ansseau M
Encephale; 1993 Aug; 19 Spec No 3():441-4. PubMed ID: 8299542
[TBL] [Abstract][Full Text] [Related]
14. Clinical use of the Hamilton Depression Rating Scale: is increased efficiency possible? A post hoc comparison of Hamilton Depression Rating Scale, Maier and Bech subscales, Clinical Global Impression, and Symptom Checklist-90 scores.
Ruhé HG; Dekker JJ; Peen J; Holman R; de Jonghe F
Compr Psychiatry; 2005; 46(6):417-27. PubMed ID: 16275208
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project.
Hennings JM; Owashi T; Binder EB; Horstmann S; Menke A; Kloiber S; Dose T; Wollweber B; Spieler D; Messer T; Lutz R; Künzel H; Bierner T; Pollmächer T; Pfister H; Nickel T; Sonntag A; Uhr M; Ising M; Holsboer F; Lucae S
J Psychiatr Res; 2009 Jan; 43(3):215-29. PubMed ID: 18586274
[TBL] [Abstract][Full Text] [Related]
16. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
17. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
Rush AJ; Sackeim HA; Marangell LB; George MS; Brannan SK; Davis SM; Lavori P; Howland R; Kling MA; Rittberg B; Carpenter L; Ninan P; Moreno F; Schwartz T; Conway C; Burke M; Barry JJ
Biol Psychiatry; 2005 Sep; 58(5):355-63. PubMed ID: 16139581
[TBL] [Abstract][Full Text] [Related]
18. Treatment-resistant depression: critique of current approaches.
Wijeratne C; Sachdev P
Aust N Z J Psychiatry; 2008 Sep; 42(9):751-62. PubMed ID: 18696279
[TBL] [Abstract][Full Text] [Related]
19. Relationship between depression severity entry criteria and antidepressant clinical trial outcomes.
Khan A; Schwartz K; Kolts RL; Ridgway D; Lineberry C
Biol Psychiatry; 2007 Jul; 62(1):65-71. PubMed ID: 17141744
[TBL] [Abstract][Full Text] [Related]
20. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.
Hollon SD; DeRubeis RJ; Shelton RC; Amsterdam JD; Salomon RM; O'Reardon JP; Lovett ML; Young PR; Haman KL; Freeman BB; Gallop R
Arch Gen Psychiatry; 2005 Apr; 62(4):417-22. PubMed ID: 15809409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
